Psychedelic therapy study for older adults with low well-being
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 85 years old
- Your overall well-being is lower than average (as measured by a short questionnaire)
- You have no memory or thinking problems (like dementia)
- You have a friend or family member who can be contacted and pick you up after the dosing visit
- You agree to use birth control if needed (for 3 months after the dosing visit)
- You can swallow capsules and are comfortable with MRI scans
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.
This study looks at how a single dose of psilocybin (the active ingredient in magic mushrooms) affects brain structure in healthy older adults. You'll receive the drug in a safe setting and have brain scans before and after to see if it promotes positive changes.
This study tests how certain psychoactive substances affect your mind and body. It is looking for healthy volunteers to take part in supervised sessions to explore the effects of these drugs.
This study tests whether combining mindfulness training with a single dose of psilocybin (a psychedelic found in certain mushrooms) can help healthy adults. It aims to explore how these two approaches together might improve well-being.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
Hear when a new Older Adults (50-90 Years) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.